| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/12/2008 | EP1896408A1 New 2-azetidinone derivatives for the treatment of hyperlipidaemic diseases |
| 03/12/2008 | EP1896136A2 Compositions having an activity of ameliorating a reduced higher brain function resulting from organic brain lesions |
| 03/12/2008 | EP1896053A1 Pharmaceutical composition comprising fgf18 and il-1 antagonist and method of use |
| 03/12/2008 | EP1896032A2 The preparation and use of compounds as protease inhibitors |
| 03/12/2008 | EP1896025A1 Scopolamine for the treatment of depression and anxiety |
| 03/12/2008 | EP1896021A1 Solid pharmaceutical preparation containing (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chroman |
| 03/12/2008 | EP1896018A2 Medical uses of 39-desmethoxyrapamycin and analogues thereof |
| 03/12/2008 | EP1896012A2 Anti-inflammatory agents |
| 03/12/2008 | EP1896004A1 Compositions ameliorating a reduced diurnal activity and/or depressive symptoms |
| 03/12/2008 | EP1732556B1 Process for the preparation of 3-amino-8-(1-piperazinyl)-2h-1-benzopyran-2-one and salts and hydrates thereof |
| 03/12/2008 | EP1708713B1 1-benzyl-5-piperazin-1-yl-3,4 dihydro-1h-quinazolin-2-one derivatives and the respective 1h-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzo(d)(1,3)oxazin-2-one derivatives as modulators of the 5-hydroxytryptamine receptor (5-ht) for the treatment of diseases of the central nervous system |
| 03/12/2008 | EP1682162B1 Use of prickly pear (opuntia) for the preparation of a medicament for the treatment of depressions |
| 03/12/2008 | EP1613596B1 N-[(piperazinyl)hetaryl]arylsulfonamide compounds with affinity for the dopamine d3 receptor |
| 03/12/2008 | EP1587799B1 Benzoxazole derivatives and their use as adenosine receptor ligands |
| 03/12/2008 | EP1578738B1 Escitalopram hydrobromide and a method for the preparation thereof |
| 03/12/2008 | EP1539693B1 Cannabinoid receptor agonists |
| 03/12/2008 | EP1534275B1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 03/12/2008 | EP1495009B1 Cyanamides useful as reversible inhibitors of cysteine proteases |
| 03/12/2008 | EP1307194B1 Fentanyl composition for nasal administration |
| 03/12/2008 | EP1210434B1 Mammalian interleukin-12 p40 and interleukin b30. combinations thereof. antibodies. uses in pharmaceutical compositions |
| 03/12/2008 | EP1178803B1 Opioid antagonists containing compositions for enhancing analgesic potency of tramadol and attenuating its adverse side effects |
| 03/12/2008 | EP0876487B1 Mammalian cx3c chemokine genes |
| 03/12/2008 | CN101142217A 咪唑并哒嗪化合物 Imidazopyridazine compounds |
| 03/12/2008 | CN101142199A [1,2,4]-dithiazoli(di)ne derivatives, inducers of gluthathione-S-transferase and N A D P H quinone oxido-reductase, for prophylaxis and treatment of adverse conditions associated with cytotoxicity in |
| 03/12/2008 | CN101142195A Substituted 2-amino-quinazolin-4-on compoundsfor use in the treatment of C N S disorders, pain, stroke, addicition and epilepsy, their preparation and use as intermediates |
| 03/12/2008 | CN101142194A Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors |
| 03/12/2008 | CN101142182A Method of preparation of pure 4-pyrrolidinophenylbenzyl ether derivatives as MAOB inhibitors |
| 03/12/2008 | CN101142180A Pyrrolidine derivatives as histamine h3 receptor antagonists |
| 03/12/2008 | CN101141964A Methods and compositions for treating diabetes, metabolic syndrome and other conditions |
| 03/12/2008 | CN101141959A 2,5-disubstituted phenyl methanone derivatives as glycine transporter 1 (Glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders |
| 03/12/2008 | CN101141958A Benzimidazole derivatives and their use for modulating the GABAA receptor complex |
| 03/12/2008 | CN101139384A 5-peptide derivative, preparation method and use thereof |
| 03/12/2008 | CN101139375A Synthesis of 1-hydrocarbyl-2-(4-beta-D-pyrane allose glycosides-phenyl)-benzimidazole derivative |
| 03/12/2008 | CN101139345A Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 03/12/2008 | CN101139331A Novel compound separated from camphor tree body and medical component |
| 03/12/2008 | CN101139285A Acetylation hypericin hypericin and its application in preparation of medicament for treating Alzheimer's disease |
| 03/12/2008 | CN101138615A Chinese medicine for treating intractable aypnia |
| 03/12/2008 | CN101138599A Smoking toxin-expelling phlegm-eliminating Chinese traditional medicine powder dip |
| 03/12/2008 | CN101138582A Use of compound red sage root tablet for producing medicine for preventing and treating diabetes chronic complication |
| 03/12/2008 | CN101138566A Prevention and treatment process for infectious diseases and other diseases by using immunity effect compounds |
| 03/12/2008 | CN101138562A Pharmaceutical composition containing sertraline for treating melancholia and correlating diseases |
| 03/12/2008 | CN101138542A Lidocaine hydrochloride partial film forming gel composition and uses thereof |
| 03/12/2008 | CN101138420A Application of hypericum seniawinii maxim in the producing of food products for improving memory of learning |
| 03/12/2008 | CN100374550C Magnetic cell and method of using the same |
| 03/12/2008 | CN100374466C Antibodies against human IL-12 |
| 03/12/2008 | CN100374440C Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesity |
| 03/12/2008 | CN100374416C P-(sulfonyl)-aryl and heteroaryls amines |
| 03/12/2008 | CN100374161C Triacetin as a transdermal penetration enhancer |
| 03/12/2008 | CN100374151C medicine compositions for generating immune and usage of prevention and treatment of amyloidogenic disease |
| 03/12/2008 | CN100374143C Gastrodia freeze dried powder injection for intravenous injection and its preparation technology |
| 03/12/2008 | CN100374134C Compound medicine for treating depression and method for preparing same |
| 03/12/2008 | CN100374125C Pharmaceutical compsn. contg. extract from barleria prionitis linn and its process of prepn |
| 03/12/2008 | CN100374120C Powder of flenabane and its preparation method as well as application in making drugs |
| 03/12/2008 | CN100374112C Intranasal formulation of rotigotine |
| 03/12/2008 | CN100374108C Compositions for promoting sleep |
| 03/12/2008 | CN100374045C Method for preparing micron pearl particle and capsule for assisting sleep, tonifying intestine and supplying calcium |
| 03/12/2008 | CN100374030C Method for preparing micron pearl soybean milk taken at night for assisting sleep, tonifying intestine and supplying calcium |
| 03/12/2008 | CN100374029C Method for preparing micron pearl soybean milk powder taken at night for assisting sleep, tonifying intestine and supplying calcium |
| 03/11/2008 | US7342131 Levodopa prodrugs, and compositions and uses thereof |
| 03/11/2008 | US7342091 Soluble cyclic analogues of β amyloid peptide |
| 03/11/2008 | US7342043 Medicinal compositions improving brain function and method for improving brain function |
| 03/11/2008 | US7342034 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 03/11/2008 | US7342032 Psychiatric and neurological disorders; cannabinoid (cb1) receptor; such as 4-(4-Chlorophenyl)-5-(2,4-dichlorophenyl)-N-(1-piperidinyl)thiazole-2-carboxamide |
| 03/11/2008 | US7342029 Substituted indoles |
| 03/11/2008 | US7342028 Medical use for tachykinin antagonists |
| 03/11/2008 | US7342025 Substituted C-imidazo[1,2-a]pyridin-3-yl-methylamines |
| 03/11/2008 | US7342024 4-Oxo-1-3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors |
| 03/11/2008 | US7342022 Compounds in the treatment of dementia related diseases, Alzheimer's Disease and conditions associated with glycogen synthase kinase-3 |
| 03/11/2008 | US7342021 Phosphodiesterase 4 inhibitors |
| 03/11/2008 | US7342019 5, 6-diaryl-pyrazine-2-amide derivatives as CB1 antagonists |
| 03/11/2008 | US7342017 Vanilloid Receptor 1 and metabotropic glutamate receptor 1 inhibitors; inhibition of capsaicin-induced or PH-induced activation of vanilloid receptors; antidepressant; anxiolytic agent; analgesics; addictive disorders; antiemetic agent |
| 03/11/2008 | US7342015 Indole derivatives |
| 03/11/2008 | US7342008 Containing a benzodiazepine ring; 2-Cyclopentylmethyl-3(S)-hydroxyl-1-oxo-5-phenylpentyl)amino-1-methyl-5-(4-fluoro-phenyl)-2,3-dihydro-1H-1,5-benzodiazepin-2-one; Alzheimer's disease and Down's Syndrome; prevent the formation of neurological deposits of amyloid protein |
| 03/11/2008 | US7342007 prevent the formation of neurological deposits of amyloid protein; Alzheimer's disease, cognitive impairment; novel lactarns; N2-[(3,5-difluorophenyl)acetyl]-N1-[(3S,7S)-1-methyl-2-oxo-7-phenyl-2,3,4,7-tetrahydro-1H-azepin-3-yl]-L-alaninamide; secretase inhibitors |
| 03/11/2008 | US7341871 Recombinant expression vector comprising promoter sequence, age regulatory sequence; can use in treatment of age-related and liver diseases; operably linking nucleic acid sequence, promoter sequence, and age regulatory sequences to produce a transgene, introducing into cell |
| 03/11/2008 | US7341842 TRP8, a transient receptor potential channel expressed in taste receptor cells |
| 03/11/2008 | US7341718 Neuronal gene transfer of adenovirus and herpes virus vectors |
| 03/11/2008 | CA2612550A1 Creatine pyroglutamic acid salts and methods for their production and use in individuals |
| 03/11/2008 | CA2444561C Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| 03/11/2008 | CA2404464C Pyrrolidine and piperidine derivatives and their use for the treatment of neurodegenerative disorders |
| 03/11/2008 | CA2335104C Arylalkanoylpyridazines |
| 03/11/2008 | CA2310664C Substituted 2-aminoacetamides and the use thereof |
| 03/06/2008 | WO2008028094A1 Compounds as cb2 cannabinoid receptor ligands |
| 03/06/2008 | WO2008028093A1 Compounds as cb2 cannabinoid receptor ligands |
| 03/06/2008 | WO2008027557A2 Topiramate compositions and methods of enhancing its bioavailability |
| 03/06/2008 | WO2008027483A1 Benzofuran derivatives as modulators of the 5-ht2a receptor |
| 03/06/2008 | WO2008027395A2 Pharmaceutical compositions of benzodiazepines and methods of use thereof |
| 03/06/2008 | WO2008027357A2 Pharmaceutical compositions of clonazepam and methods of use thereof |
| 03/06/2008 | WO2008027182A2 Indoloquinoline compounds as calcium channel blockers |
| 03/06/2008 | WO2008027017A1 Modulation of neural activity and/or condition |
| 03/06/2008 | WO2008026965A1 Substituted pyrrolo[4,3-b]indoles, combinatorial and focused libraries, pharmacological composition and a method for the production and use thereof |
| 03/06/2008 | WO2008026776A1 Transdermal composition, transdermal pharmaceutical composition and transdermal cosmetic composition comprising polymer micelle encapsulating active ingredient |
| 03/06/2008 | WO2008026704A1 Isoquinoline derivative |
| 03/06/2008 | WO2008026687A1 Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor comprising the derivative |
| 03/06/2008 | WO2008026564A1 Urea derivative |
| 03/06/2008 | WO2008026563A1 Hydrazine amide derivative |
| 03/06/2008 | WO2008026149A1 1,4,5,6, 7,8-hexahydro-i^1s-triaza-azulene derivatives as orexin receptor antagonists |
| 03/06/2008 | WO2008026046A1 Morpholine d3 dopamine antagonists |
| 03/06/2008 | WO2008025791A1 Buprenophine-wafer for drug substitution therapy |
| 03/06/2008 | WO2008025790A2 Use of opioid formulations in needle-less drug delivery devices |